avrg: GSE58827: Dynamics of the Mouse Liver
Name | miRBASE accession |
---|---|
mmu-miR-219a-5p
|
MIMAT0000664 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr6_+_86078070 Show fit | 4.08 |
ENSMUST00000032069.5
|
adducin 2 (beta) |
|
chr11_+_74619594 Show fit | 2.23 |
ENSMUST00000100866.2
|
RIKEN cDNA E130309D14 gene |
|
chr2_-_168767029 Show fit | 1.12 |
ENSMUST00000075044.3
|
sal-like 4 (Drosophila) |
|
chr3_-_36571952 Show fit | 1.08 |
ENSMUST00000029270.3
|
cyclin A2 |
|
chr7_-_116038734 Show fit | 1.01 |
ENSMUST00000166877.1
|
SRY-box containing gene 6 |
|
chr11_-_3504766 Show fit | 1.00 |
ENSMUST00000044507.5
|
inositol polyphosphate 5-phosphatase J |
|
chr13_+_108214389 Show fit | 0.91 |
ENSMUST00000022207.8
|
ELOVL family member 7, elongation of long chain fatty acids (yeast) |
|
chr11_-_109473598 Show fit | 0.86 |
ENSMUST00000070152.5
|
solute carrier family 16 (monocarboxylic acid transporters), member 6 |
|
chr5_+_91517615 Show fit | 0.82 |
ENSMUST00000040576.9
|
prostate androgen-regulated mucin-like protein 1 |
|
chr14_+_84443553 Show fit | 0.68 |
ENSMUST00000071370.5
|
protocadherin 17 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 4.1 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.1 | 1.1 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 1.1 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 1.0 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.0 | 1.0 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 0.9 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.8 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.0 | 0.7 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.0 | 0.6 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 0.5 | GO:0051794 | regulation of catagen(GO:0051794) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 4.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 1.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.5 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.4 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.0 | 0.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.4 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.4 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.3 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 0.2 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 4.1 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 1.3 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
0.3 | 1.0 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 0.9 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.6 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 0.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.4 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 0.4 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.4 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.3 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 1.0 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |